{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:11:20Z","timestamp":1792239080107,"version":"4.4.0"},"reference-count":121,"publisher":"Elsevier","isbn-type":[{"value":"9780443317484","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.ai.2024.10.011","type":"book-chapter","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T09:07:43Z","timestamp":1742893663000},"page":"137-167","source":"Crossref","is-referenced-by-count":5,"title":["Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy"],"prefix":"10.1016","member":"78","reference":[{"issue":"9553","key":"10.1016\/bs.ai.2024.10.011_bib1","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(06)69842-5","volume":"368","author":"Abgrall","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/bs.ai.2024.10.011_bib2","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Albertsen","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"11","key":"10.1016\/bs.ai.2024.10.011_bib3","first-page":"4320","article-title":"Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma","volume":"61","author":"Argani","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ai.2024.10.011_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104495","article-title":"It\u2019s all about plant derived natural phytoconstituents and phytonanomedicine to control skin cancer","volume":"84","author":"Ashique","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/bs.ai.2024.10.011_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100047","article-title":"siRNA-based nanocarriers for targeted drug delivery to control breast cancer","volume":"4","author":"Ashique","year":"2022","journal-title":"Advances in Cancer Biology-Metastasis"},{"issue":"11","key":"10.1016\/bs.ai.2024.10.011_bib6","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00210-023-02522-5","article-title":"Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC)","volume":"396","author":"Ashique","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13337-023-00824-z","article-title":"HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective","volume":"34","author":"Ashique","year":"2023","journal-title":"VirusDisease"},{"key":"10.1016\/bs.ai.2024.10.011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100041","article-title":"Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery\u2014A review","volume":"4","author":"Ashique","year":"2022","journal-title":"Advances in Cancer Biology-Metastasis"},{"key":"10.1016\/bs.ai.2024.10.011_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro\u2010transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"36","key":"10.1016\/bs.ai.2024.10.011_bib10","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.ai.2024.10.011_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2019.09.009","article-title":"A trans\u2010amplifying RNA vaccine strategy for induction of potent protective immunity","volume":"28","author":"Beissert","year":"2020","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(95)80053-0","article-title":"BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes","volume":"2","author":"Bo\u00ebl","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/bs.ai.2024.10.011_bib15","first-page":"591","article-title":"Developments in cancer vaccines for hepatocellular carcinoma","volume":"60","author":"Buonaguro","year":"2011","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib16","article-title":"Nanocarriers of antigen proteins for vaccine delivery","author":"Chaves","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.ai.2024.10.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID\u201019 vaccines: The status and perspectives in delivery points of view","volume":"170","author":"Chung","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.ai.2024.10.011_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108189","article-title":"Novel strategies exploiting interleukin-12 in cancer immunotherapy","volume":"239","author":"Cirella","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"7","key":"10.1016\/bs.ai.2024.10.011_bib19","first-page":"1397","article-title":"Characterization of a messenger RNA polynucleotide vaccine vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1440-1711.2000.00906.x","article-title":"An overview of cancer immunotherapy","volume":"78","author":"Davis","year":"2000","journal-title":"Immunology and Cell Biology"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000329","article-title":"TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: Link between T\u2010cell activation and clinical responses in advanced melanoma","volume":"8","author":"De Keersmaecker","year":"2020","journal-title":"The Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-023-01627-0","article-title":"Radiopharmaceuticals: Navigating the frontier of precision medicine and therapeutic innovation","volume":"29","author":"Dhoundiyal","year":"2024","journal-title":"European Journal of Medical Research"},{"key":"10.1016\/bs.ai.2024.10.011_bib23","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","article-title":"The intriguing history of cancer immunotherapy","volume":"10","author":"Dobosz","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jpcb.9b11095","article-title":"Molecular dynamics of the recruitment of immunoreceptorsignaling module DAP12 homodimer to lipid raft boundary regulated by PIP2","volume":"124","author":"Dong","year":"2019","journal-title":"The Journal of Physical Chemistry B"},{"issue":"5","key":"10.1016\/bs.ai.2024.10.011_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2471\/BLT.24.291388","article-title":"An mRNA technology transfer programme and economic sustainability in health care","volume":"102","author":"Dutt","year":"2024","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1261\/rna.1862210","article-title":"Rapid, nondenaturing RNA purification using weak anion\u2010exchange fast performance liquid chromatography","volume":"16","author":"Easton","year":"2010","journal-title":"RNA (New York, N. Y.)"},{"key":"10.1016\/bs.ai.2024.10.011_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2021","journal-title":"Accounts of Chemical Research"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"10.1016\/bs.ai.2024.10.011_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41577-019-0195-7","article-title":"Alternative mRNA splicing in cancer immunotherapy","volume":"19","author":"Frankiw","year":"2019","journal-title":"Nature Reviews. Immunology"},{"issue":"5","key":"10.1016\/bs.ai.2024.10.011_bib30","first-page":"13","article-title":"Cancer immunotherapy in the 21st century","volume":"42","author":"Frazer","year":"2012","journal-title":"Internal Medicine Journal"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib31","first-page":"809","article-title":"Rapid separation of low molecular weight solutes from liposomes without dilution","volume":"90","author":"Fry","year":"1978","journal-title":"AnallBiochem"},{"issue":"9","key":"10.1016\/bs.ai.2024.10.011_bib32","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1261\/rna.056614.116","article-title":"A general method for rapid and cost\u2010efficient large\u2010scale production of 5\u2032 capped RNA","volume":"22","author":"Fuchs","year":"2016","journal-title":"RNA (New York, N. Y.)"},{"key":"10.1016\/bs.ai.2024.10.011_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2020.00188","article-title":"The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease","volume":"11","author":"Garbuglia","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"21","key":"10.1016\/bs.ai.2024.10.011_bib34","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non\u2013small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib35","first-page":"152","article-title":"RNA: The new revolution in nucleic acid vaccines","volume":"25","author":"Geall","year":"2013","journal-title":"SeminImmunol"},{"key":"10.1016\/bs.ai.2024.10.011_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-6481-9_10","article-title":"Electroporation of mRNA as universal technology platform to transfect a variety of primary cells with antigens and functional proteins","volume":"1499","author":"Gerer","year":"2017","journal-title":"Methods in Molecular Biology"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: hPV vaccination after treatment for CIN2","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/bs.ai.2024.10.011_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2015.09.019","article-title":"Protamine-based nanoparticles as new antigen delivery systems","volume":"97","author":"Gonz\u00e1lez-Aramundiz","year":"2015","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib39","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAD.0000000000001276","article-title":"Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI\u2010TriMix)","volume":"31","author":"Guardo","year":"2017","journal-title":"AIDS (London, England)"},{"key":"10.1016\/bs.ai.2024.10.011_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.05.005","article-title":"RNA vaccines for cancer: Principles to practice","author":"Guasp","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ai.2024.10.011_bib42","first-page":"1112","article-title":"Phase I clinical trial of mRNA-based cancer vaccine CV8102","volume":"66","author":"Haanen","year":"2018","journal-title":"Cancer Immunotherapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102159","article-title":"Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets","volume":"35","author":"Hardenberg","year":"2024","journal-title":"Molecular Therapy\u2014Nucleic Acids"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib44","first-page":"194","article-title":"The effect of a bacterial vaccine on tumors and the immune response of ICR\/Ha mice","volume":"9","author":"Havas","year":"1990","journal-title":"Journal of Biological Response Modifiers"},{"key":"10.1016\/bs.ai.2024.10.011_bib45","article-title":"Methods for purification of messenger RNA","author":"Heartlein","year":"2018","journal-title":"Google Patents"},{"issue":"10","key":"10.1016\/bs.ai.2024.10.011_bib46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nature Reviews. Immunology"},{"issue":"12","key":"10.1016\/bs.ai.2024.10.011_bib47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nature Reviews Materials"},{"key":"10.1016\/bs.ai.2024.10.011_bib48","doi-asserted-by":"crossref","unstructured":"Isaac, I., Bhatia, M., & Bhattacharya, C. (2024). Recent advances in biomaterials for mRNA delivery to immune cells. ACS Applied Bio Materials.","DOI":"10.1021\/acsabm.4c00734"},{"issue":"4","key":"10.1016\/bs.ai.2024.10.011_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/vaccines7040209","article-title":"Therapeutic vaccine in chronically HIV\u20101\u2010infected patients: a randomized, double\u2010blind, placebo\u2010controlled phase IIa trial with HTI\u2010TriMix","volume":"7","author":"Jong","year":"2019","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1078-0432.CCR-20-0245","article-title":"The changing landscape of therapeutic cancer vaccines\u2010novel platforms and neoantigen identification","volume":"27","author":"Jou","year":"2021","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"09","key":"10.1016\/bs.ai.2024.10.011_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0076-6879(09)63022-6","article-title":"Chapter 22 Ion\u2010exchange chromatography","volume":"463","author":"Jungbauer","year":"2009","journal-title":"Methods in Enzymology"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2024","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/vaccines9010003","article-title":"Resources, production scales and time required for producing RNA vaccines for the global pandemic demand","volume":"9","author":"Kis","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/bs.ai.2024.10.011_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: Advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Molecular Therapy"},{"issue":"7607","key":"10.1016\/bs.ai.2024.10.011_bib55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"22","key":"10.1016\/bs.ai.2024.10.011_bib56","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1158\/0008-5472.CAN-10-0699","article-title":"Intranodal vaccination with naked antigen\u2010encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity","volume":"70","author":"Kreiter","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ai.2024.10.011_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2017.11.034","article-title":"Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine","volume":"156","author":"Kwon","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/bs.ai.2024.10.011_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2018.03.035","article-title":"Preclinical evaluation of mRNA trimannosylatedlipopolyplexes as therapeutic cancer vaccines targeting dendritic cells","volume":"278","author":"Le Moignic","year":"2018","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"8","key":"10.1016\/bs.ai.2024.10.011_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: Current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/bs.ai.2024.10.011_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.12.003","article-title":"Cancer\u2010associated fibroblasts in tumor microenvironment\u2013accomplices in tumor malignancy","volume":"343","author":"Liao","year":"2019","journal-title":"Cellular Immunology"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib61","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12967-023-04724-0","article-title":"Advancing personalized medicine in brain cancer: Exploring the role of mRNA vaccines","volume":"21","author":"Lin","year":"2023","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA vaccine to balance innate\/adaptive immune response","volume":"26","author":"Linares\u2010Fern\u00e1ndez","year":"2020","journal-title":"Trends in Molecular Medicine"},{"issue":"8","key":"10.1016\/bs.ai.2024.10.011_bib63","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ai.2024.10.011_bib64","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liu","year":"2021","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"28","key":"10.1016\/bs.ai.2024.10.011_bib65","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.2174\/0929867328666201229123151","article-title":"OX40 and OX40L interaction in cancer","volume":"28","author":"Lu","year":"2021","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"10.1016\/bs.ai.2024.10.011_bib66","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1261\/rna.5264804","article-title":"Large\u2010scale preparation and purification of polyacrylamide\u2010free RNA oligonucleotides","volume":"10","author":"Lukavsky","year":"2004","journal-title":"RNA (New York, N. Y.)"},{"issue":"4","key":"10.1016\/bs.ai.2024.10.011_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/vaccines4040039","article-title":"Replicon RNA viral vectors as vaccines","volume":"4","author":"Lundstrom","year":"2016","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/bs.ai.2024.10.011_bib68","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1073\/pnas.90.4.1435","article-title":"Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat","volume":"90","author":"Maciejewski\u2010Lenoir","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ai.2024.10.011_bib69","series-title":"Peptide and protein in vaccine delivery","first-page":"217","author":"Mandhane","year":"2024"},{"issue":"22","key":"10.1016\/bs.ai.2024.10.011_bib70","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2217\/nnm-2020-0220","article-title":"Peptide\u2010based combination nanoformulations for cancer therapy","volume":"15","author":"Mehrotra","year":"2020","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"key":"10.1016\/bs.ai.2024.10.011_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PPO.0000000000000240","article-title":"Adoptive cell therapy for metastatic melanoma","volume":"23","author":"Merhavi-Shoham","year":"2017","journal-title":"The Cancer Journal"},{"key":"10.1016\/bs.ai.2024.10.011_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0076-6879(89)80091-6","article-title":"Synthesis of small RNAs using T7 RNA polymerase","volume":"180","author":"Milligan","year":"1989","journal-title":"Methods in Enzymology"},{"key":"10.1016\/bs.ai.2024.10.011_bib73","article-title":"Hybrid nanocarriers for neurological disorders: Diagnostic & therapeutic approach","author":"Mishra","year":"2022","journal-title":"Recent Patents on Nanotechnology"},{"issue":"6","key":"10.1016\/bs.ai.2024.10.011_bib74","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2174\/1567201811666140709112040","article-title":"Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery","volume":"11","author":"Mishra","year":"2014","journal-title":"Current Drug Delivery"},{"key":"10.1016\/bs.ai.2024.10.011_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2024.2333123","article-title":"mRNA vaccine designs for optimal adjuvanticity and delivery","volume":"21","author":"Mochida","year":"2024","journal-title":"RNA Biology"},{"key":"10.1016\/bs.ai.2024.10.011_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib77","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-024-02701-3","article-title":"Inorganic nanoparticle-based treatment approaches for colorectal cancer: Recent advancements and challenges","volume":"22","author":"Narayana","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.ai.2024.10.011_bib78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nano.2018.09.004","article-title":"Protein-based nanoparticles in cancer vaccine development","volume":"15","author":"Neek","year":"2019","journal-title":"Nanomedicine Nanotechnology Biology and Medicine"},{"issue":"15_suppl","key":"10.1016\/bs.ai.2024.10.011_bib79","first-page":"3015","article-title":"Personalized neoantigen RNA mutanome vaccine for solid tumors: Phase I trial results","volume":"38","author":"Nogueira-Rodrigues","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/jvi.15.1.199-207.1975","article-title":"Identification of the in vitro translation products of adenovirus mRNA by immunoprecipitation","volume":"15","author":"Oberg","year":"1975","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib81","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Letters"},{"issue":"4","key":"10.1016\/bs.ai.2024.10.011_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nature Reviews. Cancer"},{"issue":"15_","key":"10.1016\/bs.ai.2024.10.011_bib83","first-page":"2545","article-title":"Phase I\/II study of mRNA-based cancer vaccine (mRNA-5671) targeting KRAS mutations","volume":"37","author":"Papachristofilou","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.ai.2024.10.011_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"4","key":"10.1016\/bs.ai.2024.10.011_bib85","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nature Reviews. Cancer"},{"issue":"8","key":"10.1016\/bs.ai.2024.10.011_bib86","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/biom14081036","article-title":"Enhancing vaccine efficacy and stability: A review of the utilization of nanoparticles in mRNA vaccines","volume":"14","author":"Parvin","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/bs.ai.2024.10.011_bib87","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA\u2010based vaccines","volume":"4","author":"Pascolo","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.critrevonc.2017.05.001","article-title":"Melanoma antigens and related immunological markers","volume":"115","author":"Pitcovski","year":"2017","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/bs.ai.2024.10.011_bib89","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"27","key":"10.1016\/bs.ai.2024.10.011_bib90","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid\u201019 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"The New England Journal of Medicine"},{"issue":"17","key":"10.1016\/bs.ai.2024.10.011_bib91","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"15","key":"10.1016\/bs.ai.2024.10.011_bib92","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid\u2010specific, saturable and ion dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Therapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Therapeutic Delivery"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib94","first-page":"41","article-title":"Attempts to study the localization of liposomes and liposome entrapped antigen in the spleen","volume":"65","author":"Rooijen","year":"1979","journal-title":"ActaHistochem"},{"key":"10.1016\/bs.ai.2024.10.011_bib95","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.ejhg.5200891","article-title":"New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have cancer\/testis expression profile","volume":"10","author":"Ruault","year":"2002","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/bs.ai.2024.10.011_bib96","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/nano11061508","article-title":"Use of protamine in nanopharmaceuticals\u2014A review","volume":"11","author":"Ruseska","year":"2021","journal-title":"Nanomaterials"},{"issue":"7823","key":"10.1016\/bs.ai.2024.10.011_bib97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/bs.ai.2024.10.011_bib98","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.ai.2024.10.011_bib99","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00262-005-0078-6","article-title":"Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate","volume":"55","author":"Salcedo","year":"2006","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.ai.2024.10.011_bib100","first-page":"1","article-title":"Cancer mRNA vaccines: Clinical advances and future opportunities","author":"Sayour","year":"2024","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"15","key":"10.1016\/bs.ai.2024.10.011_bib101","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","article-title":"Cancer vaccines: Building a bridge over troubled waters","volume":"185","author":"Sellars","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib102","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/pharmaceutics14020398","article-title":"Lipid nanoparticle delivery systems to enable mRNA-based therapeutics","volume":"14","author":"Semple","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.ai.2024.10.011_bib103","series-title":"Advanced vaccination technologies for infectious and chronic diseases","first-page":"311","article-title":"Vaccine safety, efficacy, and ethical considerations","author":"Shukla","year":"2024"},{"key":"10.1016\/bs.ai.2024.10.011_bib104","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","article-title":"Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification","volume":"12","author":"Sriram","year":"2018","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/bs.ai.2024.10.011_bib105","unstructured":"Stojanovic, V. (2022). The development of reconstituted translation system for peptidomimetic mRNA display synthesis (Master\u2019s thesis). 1961. Accessed December 15, 2022. https:\/\/open.library.ubc.ca\/media\/stream\/pdf\/24\/1.0066852\/1."},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib106","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/bs.ai.2024.10.011_bib107","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/bs.ai.2024.10.011_bib108","doi-asserted-by":"crossref","first-page":"1433185","DOI":"10.3389\/fimmu.2024.1433185","article-title":"Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?","volume":"15","author":"Tadic","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.ai.2024.10.011_bib109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<125::AID-PROS8>3.0.CO;2-Y","article-title":"Follow\u2010up evaluation of a phase II prostate cancer vaccine trial","volume":"40","author":"Tjoa","year":"1999","journal-title":"The Prostate"},{"issue":"6477","key":"10.1016\/bs.ai.2024.10.011_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science (New York, N. Y.)"},{"issue":"26","key":"10.1016\/bs.ai.2024.10.011_bib111","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.ai.2024.10.011_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/bs.ai.2024.10.011_bib113","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2174\/0113816128296588240321072042","article-title":"Innovative strategies to enhance mRNA vaccine delivery and effectiveness: Mechanisms and future outlook","volume":"30","author":"Verma","year":"2024","journal-title":"Current Pharmaceutical Design"},{"issue":"7","key":"10.1016\/bs.ai.2024.10.011_bib114","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2103","article-title":"Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo","volume":"7","author":"Villadangos","year":"2007","journal-title":"Nature Reviews. Immunology"},{"issue":"1\u20104","key":"10.1016\/bs.ai.2024.10.011_bib115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0377-0273(90)90043-F","article-title":"Gradients in physical parameters in zoned felsic magma bodies: Implications for evolution and eruptive withdrawal","volume":"43","author":"Wolff","year":"1990","journal-title":"Journal of Volcanology and Geothermal Research"},{"key":"10.1016\/bs.ai.2024.10.011_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114117","article-title":"Emerging peptide-based nano vaccines: From design synthesis to defense against cancer and infection","volume":"158","author":"Xu","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"18","key":"10.1016\/bs.ai.2024.10.011_bib117","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.3390\/ijms21186582","article-title":"mRNA vaccine era\u2010mechanisms, drug platform and clinical prospection","volume":"21","author":"Xu","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.ai.2024.10.011_bib118","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40364-023-00449-w","article-title":"Advances of mRNA vaccine in tumor: A maze of opportunities and challenges","volume":"11","author":"Yuan","year":"2023","journal-title":"Biomarker Research"},{"key":"10.1016\/bs.ai.2024.10.011_bib119","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1021\/acsomega.3c08353","article-title":"Lipid nanoparticle-based delivery system\u2500A competing place for mRNA vaccines","volume":"9","author":"Zhang","year":"2024","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/bs.ai.2024.10.011_bib120","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.vaccine.2016.05.073","article-title":"Personalized cancer vaccines: Targeting the cancer mutanome","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/bs.ai.2024.10.011_bib121","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/acs.biomac.4c00365","article-title":"Constructing a ready-to-use mRNA vaccine delivery system for the prevention of influenza A virus, utilizing FDA-approved raw materials","volume":"25","author":"Zhang","year":"2024","journal-title":"Biomacromolecules"}],"container-title":["Advances in Immunology","Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006527762400083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006527762400083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:55:17Z","timestamp":1753689317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006527762400083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443317484"],"references-count":121,"URL":"https:\/\/doi.org\/10.1016\/bs.ai.2024.10.011","relation":{},"ISSN":["0065-2776"],"issn-type":[{"value":"0065-2776","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}